Skip to main content
Clinical Trials/ACTRN12617000469314
ACTRN12617000469314
Suspended
未知

An examination of whether measures of brain function and structure in subacute post-stroke aphasia predict language recovery (naming and comprehension) and word retrieval treatment response at 3 months and 6 months post stroke-onset.

Professor David Copland0 sites115 target enrollmentMarch 31, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Professor David Copland
Enrollment
115
Status
Suspended
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 31, 2017
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Professor David Copland

Eligibility Criteria

Inclusion Criteria

  • People with aphasia:
  • \- Single, first, left hemisphere stroke (as confirmed by CT/MRI) and speech and language impairment as identified by a speech pathologist or other relevant medical, nursing or allied health staff
  • \-Below the aphasia cut\-off (93\.8 AQ) on the Western Aphasia Battery \- Revised (WAB\-R) or asphasia (including high level language deficits) as identified by a speech pathologist or other relevant medical, nursing or allied health staff
  • \- MRI compatibility, and able to complete behavioural battery between 2 and 6 weeks post\-stroke
  • \- Have sufficient vision and hearing to complete the imaging and behavioural tasks
  • \- Medically stable and able to attend and participate in a therapy program (8 weeks)
  • \- English as a primary language prior to stroke
  • Control Group:
  • \- healthy older adults matched for age and gender.

Exclusion Criteria

  • People with aphasia:
  • \- Any other neurological disease or disorder, mental illness, head trauma, alcoholism, cerebral tumour or abscess.
  • \- Any metals present in the body or other contraindications for MRI including claustrophobia.
  • \- Current diagnosis of major clinical depression or other mental health condition that may affect participation.
  • \- Severe dysarthria or apraxia of speech as determined by a speech pathologist.
  • \- Severe auditory comprehension deficits as determined by the WAB\-R which would preclude following directions for the scan.
  • \- Substance abuse or dependence in the last 12 months.
  • Healthy controls:
  • \- Any brain/neurological disorder, mental illness, head trauma, alcoholism and cerebral tumour
  • \- Any contraindications for MRI – claustrophobia or metals in the body e.g., pacemaker, heart valve, dental bridge metal mesh implants/clips/wire sutures, hearing implant etc.

Outcomes

Primary Outcomes

Not specified

Similar Trials